The effect of Famciclovir (FCV) on herpes simplex virus type 1 (HSV-1) corneal disease, latency and reactivation in the rabbit eye model

被引：0
|
作者：
Loutsch, JM
Sainz, B
Marquart, ME
Zheng, X
van der Keyl, HK
Hill, JM
Tal-Singer, R
机构：
[1] LSU Eye Ctr, New Orleans, LA USA
[2] SmithKline Beecham Pharmaceut, Collegeville, PA USA
来源：
ANTIVIRAL RESEARCH | 2000年 / 46卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
130
引用
收藏
页码：A77 / A77
页数：1
相关论文
共 50 条
  • [21] NEURONAL HERPES-SIMPLEX VIRUS TYPE-1 (HSV-1) DNA INCREASES DURING LATENCY
    LIU, WG
    HALFORD, WP
    SEOANE, L
    ROSENBOHM, TM
    GEBHARDT, BM
    HILL, JM
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 1993, 34 (04) : 1349 - 1349
  • [22] Role of herpes simplex virus type 1 (HSV-1) in the pathogenesis of peptic ulcer disease
    Tsamakides, KX
    Panotopoulou, E
    Dimitroulopoulos, DA
    Christopoulou, M
    Xinopoulos, D
    Goula, E
    Kontou, M
    Archavlis, E
    Kottaridis, S
    Paraskevas, E
    GASTROENTEROLOGY, 2001, 120 (05) : A136 - A137
  • [23] CD8+ T cells can block herpes simplex virus type 1 (HSV-1) reactivation from latency in sensory neurons
    Liu, T
    Khanna, KM
    Chen, XP
    Fink, DJ
    Hendricks, RL
    JOURNAL OF EXPERIMENTAL MEDICINE, 2000, 191 (09): : 1459 - 1466
  • [24] Importance of herpes simplex virus type-1 (HSV-1) in primary genital herpes
    Nieuwenhuis, RF
    van Doornum, GJJ
    Mulder, PGH
    Neumann, HAM
    van der Meijden, WI
    ACTA DERMATO-VENEREOLOGICA, 2006, 86 (02) : 129 - 134
  • [25] The efficacy of a DNA vaccine encoding herpes simplex virus type 1 (HSV-1) glycoprotein D in decreasing ocular disease severity following corneal HSV-1 challenge
    Frye, TD
    Chiou, HC
    Hull, BE
    Bigley, NJ
    ARCHIVES OF VIROLOGY, 2002, 147 (09) : 1747 - 1759
  • [26] The efficacy of a DNA vaccine encoding herpes simplex virus type 1 (HSV-1) glycoprotein D in decreasing ocular disease severity following corneal HSV-1 challenge
    T. D. Frye
    H. C. Chiou
    B. E. Hull
    N. J. Bigley
    Archives of Virology, 2002, 147 : 1747 - 1759
  • [27] Herpes simplex virus 1 (HSV-1) for cancer treatment
    Shen, Y.
    Nemunaitis, J.
    CANCER GENE THERAPY, 2006, 13 (11) : 975 - 992
  • [28] Herpes simplex virus 1 (HSV-1) for cancer treatment
    Y Shen
    J Nemunaitis
    Cancer Gene Therapy, 2006, 13 : 975 - 992
  • [29] Decreased reactivation of a herpes simplex virus type 1 (HSV-1) latency-associated transcript (LAT) mutant using the in vivo mouse UV-B model of induced reactivation
    Lbachir BenMohamed
    Nelson Osorio
    Ruchi Srivastava
    Arif A. Khan
    Jennifer L. Simpson
    Steven L. Wechsler
    Journal of NeuroVirology, 2015, 21 : 508 - 517
  • [30] Decreased reactivation of a herpes simplex virus type 1 (HSV-1) latency-associated transcript (LAT) mutant using the in vivo mouse UV-B model of induced reactivation
    BenMohamed, Lbachir
    Osorio, Nelson
    Srivastava, Ruchi
    Khan, Arif A.
    Simpson, Jennifer L.
    Wechsler, Steven L.
    JOURNAL OF NEUROVIROLOGY, 2015, 21 (05) : 508 - 517
12345